Abstract
Recent progress in mammalian genomics raises enormous expectations for rapid advances in global understanding of the genetic program. The Human Genome Sequencing Project and parallel sequencing efforts addressing other genomes are in their final stages and will bring to the public domain an influx of tens of thousands of previously unknown genes whose cellular function will remain to be evaluated. Although DNA sequence information may assist and facilitate functional and comparative analyses of model organisms, a combination of systematic genotype- and phenotype-driven functional approaches will play a critical role in the upcoming research defining the gene function. For its physiological similarity to humans and for its genetic manipulability, the mouse emerges as a key model mammalian organism in these efforts. One powerful strategy for phenotype-driven mutagenesis studies in mice combines chromosome engineering techniques with mutagenesis. There are three key elements of this strategy. First, using the LoxP / Cre recombination system in embryonic stem (ES) cells, coat color-tagged segmental deletion s and inversions are generated on selected chromosomes, and mouse strains are derived from these cells using conventional ES cell technology. These mice can serve as very potent and extremely convenient genetic tools that narrow the search area for gene(s) of interest to a limited chromosomal segment. Second, N-ethyl-N-nitrosourea, ENU, is used to mutagenize male mice in order to generate a source of genome-wide germ-line transmissible mutations. Third, mutagenized animals are crossed with inversion or deletion carriers to produce pedigrees uncovering ENU-induced recessive phenotypes. The genomic position of induced mutations underlying recessive phenotypes is instantly mapped to the chromosomal inversion or deletion intervals. Several large-scale projects have been launched using ENU alone or in combination with engineered chromosomes. A rapidly growing set of new phenotypes has begun to emerge from these studies which will ultimately provide insights into gene function.
Current Genomics
Title: Chromosome Engineering and ENU Mutagenesis: Their Use for Defining Gene Function
Volume: 4 Issue: 1
Author(s): Jan Klysik, Monica J. Justice and Allan Bradley
Affiliation:
Abstract: Recent progress in mammalian genomics raises enormous expectations for rapid advances in global understanding of the genetic program. The Human Genome Sequencing Project and parallel sequencing efforts addressing other genomes are in their final stages and will bring to the public domain an influx of tens of thousands of previously unknown genes whose cellular function will remain to be evaluated. Although DNA sequence information may assist and facilitate functional and comparative analyses of model organisms, a combination of systematic genotype- and phenotype-driven functional approaches will play a critical role in the upcoming research defining the gene function. For its physiological similarity to humans and for its genetic manipulability, the mouse emerges as a key model mammalian organism in these efforts. One powerful strategy for phenotype-driven mutagenesis studies in mice combines chromosome engineering techniques with mutagenesis. There are three key elements of this strategy. First, using the LoxP / Cre recombination system in embryonic stem (ES) cells, coat color-tagged segmental deletion s and inversions are generated on selected chromosomes, and mouse strains are derived from these cells using conventional ES cell technology. These mice can serve as very potent and extremely convenient genetic tools that narrow the search area for gene(s) of interest to a limited chromosomal segment. Second, N-ethyl-N-nitrosourea, ENU, is used to mutagenize male mice in order to generate a source of genome-wide germ-line transmissible mutations. Third, mutagenized animals are crossed with inversion or deletion carriers to produce pedigrees uncovering ENU-induced recessive phenotypes. The genomic position of induced mutations underlying recessive phenotypes is instantly mapped to the chromosomal inversion or deletion intervals. Several large-scale projects have been launched using ENU alone or in combination with engineered chromosomes. A rapidly growing set of new phenotypes has begun to emerge from these studies which will ultimately provide insights into gene function.
Export Options
About this article
Cite this article as:
Klysik Jan, Justice J. Monica and Bradley Allan, Chromosome Engineering and ENU Mutagenesis: Their Use for Defining Gene Function, Current Genomics 2003; 4 (1) . https://dx.doi.org/10.2174/1389202033350155
DOI https://dx.doi.org/10.2174/1389202033350155 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Genomic Insights into Oncology: Harnessing Machine Learning for Breakthroughs in Cancer Genomics.
This special issue aims to explore the cutting-edge intersection of genomics and oncology, with a strong emphasis on original data and experimental validation. While maintaining the focus on how machine learning and advanced data analysis techniques are revolutionizing our understanding and treatment of cancer, this issue will prioritize contributions that ...read more
Integrating Artificial Intelligence and Omics Approaches in Complex Diseases
Recent advancements in AI and omics methodologies have revolutionized the landscape of biomedical research, enabling us to extract valuable information from vast amounts of complex data. By combining AI algorithms with omics technologies such as genomics, proteomics, metabolomics, and transcriptomics, researchers can obtain a more comprehensive and multi-dimensional analysis of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cancer Stem Cells and the Tumor Microenvironment: Soloists or Choral Singers
Current Pharmaceutical Biotechnology Advances in the Development of Class I Phosphoinositide 3-Kinase (PI3K) Inhibitors
Current Topics in Medicinal Chemistry Evidences for iNOS Expression and Nitric Oxide Production in the Human Macrophages
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Tocotrienols and Cardiovascular Health
Current Pharmaceutical Design The Relationship Between Oncogene Expression and Clinical Outcome in Endometrial Carcinoma
Current Cancer Drug Targets Kidney Diseases and Chemokines
Current Drug Targets Mesenchymal Stem Cells in Cartilage Regeneration
Current Stem Cell Research & Therapy Anti-Invasive and Anti-Metastasis Strategies: New Roads, New Tools and New Hopes
Current Cancer Drug Targets Development of Crystalline Cellulosic Fibres for Sustained Release of Drug
Current Topics in Medicinal Chemistry Mechanical Circulatory Support in Children
Current Cardiology Reviews Noscapine and its Analogs as Chemotherapeutic Agent: Current updates
Current Topics in Medicinal Chemistry The Importance of Alkynyl Chain Presence for the Activity of Adenine Nucleosides/Nucleotides on Purinergic Receptors
Current Medicinal Chemistry S-nitrosation/Denitrosation in Cardiovascular Pathologies: Facts and Concepts for the Rational Design of S-nitrosothiols
Current Pharmaceutical Design Transient Receptor Potential Channels, the Kidney and Hypertension
Current Hypertension Reviews Therapeutic Value of an Integrin Antagonist in Prostate Cancer
Current Drug Targets Design, Synthesis and Docking Study of Some Novel Isatin- Quinoline Hybrids as Potential Antitubercular Agents
Anti-Infective Agents Novel Agents to Manage Dyslipidemias and Impact Atherosclerosis
Cardiovascular & Hematological Disorders-Drug Targets TGF-Beta Type I Receptor (Alk5) Kinase Inhibitors in Oncology
Current Pharmaceutical Biotechnology Iron Chelating Strategies in Systemic Metal Overload, Neurodegeneration and Cancer
Current Medicinal Chemistry Sunscreening and Photosensitizing Properties of Coumarins and their Derivatives
Letters in Drug Design & Discovery